| Application no. and date | 12778010.4 (espacenet) (Federated) (European Patent Register), 20121011 | | Patent/reg. no. and date | DK/EP 2766040, 20190515 | | Publication date | 20140820 | | Priority no. and date | US 201161547535 P, 20111014, US 201161567015 P, 20111205, US 201261657669 P, 20120608, US 201261682037 P, 20120810, US 201261694584 P, 20120829 | | EP pub. no. and date |
EP 2766040 20140820 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Base, CH | | Applicant ref. no. | P68993DK01 | | Inventor | CLARK, Emma L., c/o Roche Products Limited
6 Falcon Way
Shire Park Hexagon Place
Welwyn Garden City
Hertfordshire AL7 1TW, GB,
RATNAYAKE, Jayantha, c/o Roche Products Limited
6 Falcon Way
Shire Park Hexagon Place
Welwyn Garden City
Hertfordshire AL7 1TW, GB,
ROSS, Graham A., c/o Roche Products Limited
6 Falcon Way
Shire Park Hexagon Place
Welwyn Garden City
Hertfordshire AL7 1TW, GB,
ALAVATTAM, Sreedhara, c/o Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080, US,
AMLER, Lukas C., c/o Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080, US,
BENYUNES, Mark C., c/o Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080, US,
DE TOLEDO PELIZON, Christina H., c/o F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel, CH,
KWONG GLOVER, Zephania W., c/o Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080, US,
MITCHELL, Lada, c/o F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel, CH,
WALKER, Ru-Amir, c/o Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , C07K 16/32 (2006.01) | | Title | Pertuzumab, trastuzumab, docetaxel og carboplatin til behandling af brystkræft i et tidligt stadie | | Int. application no. | US2012059683 | | Int. publication no. | WO2013055874 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
